Besides the mutations in EGFR and KRAS, the targetable translocation EML4-ALK recurrently occurs in lung adenocarcinoma [23] and is most frequent in tumours with mucinous signet-ring appearance. The gene discussed is EGFR; the disease is lung adenocarcinoma.